Compare Aehr Test Systems (AEHR) vs Bath & Body Works Inc (BBWI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aehr Test Systems vs Bath & Body Works Inc — how do they compare? Aehr Test Systems trades at $131.81 (market cap $3.82B), while Bath & Body Works Inc trades at $18.21 (market cap $3.81B). The key difference: Aehr Test Systems and Bath & Body Works Inc are close in size by market cap, and Bath & Body Works Inc pays a 4.24% dividend while Aehr Test Systems pays none. Which is the better fit depends on your goals.
| AEHR | BBWI | |
|---|---|---|
Market Cap | $3.82B | $3.81B |
Sector | Technology | Consumer Cyclical |
52-Week High | $117.18 | $31.87 |
52-Week Low | $17.38 | $14.85 |
Enterprise Value | $3.72B | $7.70B |
Dividend Yield | — | 4.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AEHR Test Systems (AEHR) surged 25.02% to $132.77, driven by strong earnings beats and a $22 million follow-on order for AI processor wafer-level burn-in systems (Accesswire, August 12, 2026). The stock exhibits bullish technical signals with support at $112 and resistance at $129, though RSI suggests overbought conditions. Revenue reached $58.97 million in 2025, but net income remained negative at -$3.91 million, reflecting high growth investments.
Outlook is optimistic due to AI and silicon photonics demand, with FY27 revenue growth projected at 160–200% (Seeking Alpha, July 18, 2026). Risks include customer concentration and negative cash flow. Analysts are mixed (33% buy, 67% hold), highlighting valuation concerns at a P/S of 71.87. Upside potential exists if execution aligns with backlog growth.
BBWI trades at $18.48, down 4.35% today, reflecting bearish technical signals but attractive valuations with a P/E of 5.36 and P/S of 0.54. Recent earnings show mixed results, with Q1 2026 beating estimates, while revenue has declined over five years. The company maintains strong gross margins above 43% and positive cash flow, supported by strategic expansions into Brazil and a partnership with Ulta Beauty announced in June 2026.
The stock presents a value opportunity given low multiples and analyst consensus price target of $22.11, though risks include persistent revenue declines, high debt levels, and negative shareholder equity. Investor sentiment is cautiously optimistic amid turnaround efforts, but technical weakness suggests near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →
